Dlouhy, I., Maia, T., Viegas, D., Abreu, N., Cabeçadas, J. and da Silva, M. G. (2020) “Notable clinical activity of immune checkpoint inhibitors with or without brentuximab vedotin in relapsed or refractory gray zone lymphoma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301128.